A global-first, UNSW-led trial of an HIV prevention medication has resulted in an almost one-third decline in infections in the large-scale target group.
An increase in condomless sex in pre-exposure prophylaxis users is predictable as preventing HIV is the key motivator for condom use among gay and bisexual men.
NSW is on track to virtually eliminate HIV transmission by 2020 as an expanded PrEP trial, led by the Kirby Institute at UNSW, enrols its one thousandth participant in record time.
A landmark clinical trial led by UNSW researchers aims to halve new HIV infections in NSW within two years and 'virtually eliminate' HIV transmission by 2020.
